Brief: EBR Systems Says FDA Commenced Substantive Review Of Its PMA Application
30/09/2024 02:24
Sept 30 (Reuters) - EBR Systems Inc EBR.AX :
* FDA COMMENCES SUBSTANTIVE REVIEW OF EBR'S PMA APPLICATION
* ANTICIPATES FDA'S REGULATORY APPROVAL IN Q1 CY2025
Source text for Eikon: ID:nASX9TRCQ7
Further company coverage: EBR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EBR Systems
See all newsBrief: EBR Systems Seeks Trading Halt
Brief: EBR Systems Secures Purchasing Agreement With Christus Health
Australia's EBR Systems jumps on securing U.S. purchase agreement
Brief: EBR Systems Purchasing Agreement Secured With HCA Healthcare
Brief: Ebr Systems Inc Says TGA Grants Priority Review Determination For Wise System